Moderna, Inc.
MRNA· Nasdaq
Moderna, Inc.
- Last sale
- Oct 2, 2026 · +0.55%
- Market cap
- $75.84B
- 399.24M shares
- Filings
- 1,041
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,944,000,000 | reported | |
| FY 2024 | 2024-12-31 | $3,236,000,000 | reported | |
| FY 2023 | 2023-12-31 | $6,848,000,000 | reported | |
| FY 2022 | 2022-12-31 | $19,263,000,000 | reported | |
| FY 2021 | 2021-12-31 | $18,471,000,000 | reported | |
| FY 2020 | 2020-12-31 | $803,000,000 | reported | |
| FY 2019 | 2019-12-31 | $60,209,000 revised | reported | |
| FY 2018 | 2018-12-31 | $135,068,000 | reported | |
| FY 2017 | 2017-12-31 | $205,825,000 | reported | |
| FY 2016 | 2016-12-31 | $108,396,000 | reported |
Moderna, Inc. · CIK 1682852 · Engraved from SEC EDGAR
